Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Shareholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Cost of Common Stock in Treasury
Beginning balance at Dec. 31, 2019 $ 106,511 $ (450) $ 10,300 $ 37,407 $ 70,552 $ (450) $ (11,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (1,178)       (1,178)    
Issuance of shares of common stock from the treasury 0     (708)     708
Stock-based compensation 336     336      
Purchase of common stock (635)           (635)
Ending balance at Mar. 31, 2020 104,584   10,300 37,035 68,924   (11,675)
Beginning balance at Dec. 31, 2020 80,295   10,300 37,719 42,835   (10,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 1,094       1,094    
Issuance of shares of common stock from the treasury 0     (238)     238
Stock-based compensation 187     187      
Ending balance at Mar. 31, 2021 $ 81,576   $ 10,300 $ 37,668 $ 43,929   $ (10,321)